London, 2nd December 2019: NMC Health plc (LSE:NMC) ('NMC'), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, today received notification from Mark Tompkins, Joint Chairman of the Company, that on 28th November he gifted to his spouse, Sarah Tompkins, 7292 ordinary shares of 10p each in the Company ("Shares") which were then transferred from Sarah Tompkins to Turut Holding Ltd, a company 100% owned by the Tiger Trust, a family trust.
Following this transaction, Mr Tompkins's share interest remains unchanged at a total of 51,233 shares representing approximately 0.01% of the issued share capital of the Company.
The Notification of Dealing Form for Mark Tompkins and Sarah Tompkins can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Details of the person discharging managerial responsibilities / person closely associated
Mark Tompkins & Sarah Tompkins
Joint Chairman & Joint Chairman Spouse
Initial notification /Amendment
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Nature of the transaction
Share transfer to spouse (Sarah Tompkins) followed by a share transfer from Sarah Tompkins to Turut Holding LTD which is a company 100 per cent owned by the Tiger Trust, a family trust.
Transfer Price(s) and volume(s) Mark Tompkins to Sarah Tompkins
Transfer Price(s) and volume(s) Sarah Tompkins to Turut Trust
No. of shares
No. of shares
7292 & 7292
Date of the transaction
28th November 2019
Place of the transaction
Not on a Trading Venue
Simon Watkins, Group Company Secretary
+44 (0)20 3205 7313
FTI Consulting, London
+44 (0)20 3727 1000
FTI Consulting, Gulf
+971 (0)4 437 2100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...